Navigation Links
Injury Lawyers Release New Informational Graphic about the Alleged Link Between Victoza and Cancer
Date:9/6/2013

(PRWEB) September 06, 2013

Victoza (liraglutide) is a once-daily injection used to control blood sugar levels in type-2 diabetes patients. This medicine increases insulin while making the stomach feel full. The FDA approved this drug in January 2010 and it earned more than $2.3 billion in sales its first year on the market (i). Victoza, like all medicines, may cause side effects. According to the product’s website, the most common Victoza side effects were headache, nausea, and diarrhea. The manufacturer also warns that this drug may cause low blood sugar, pancreatitis, and cancer (ii). People who have suffered pancreatic cancer or thyroid cancer should talk to a personal injury attorney about their legal options.

As early as 2009 the FDA was concerned about the association between Victoza and cancer. The Agency reviewed the safety of the medicine in April 2009 and discovered twenty-nine cases of growths and tumors, including five cases of prostate cancer and five cases of thyroid cancer (iii). In June 2011, the FDA released new safety information on the drug highlighting the risk of thyroid cancer and acute pancreatitis with Victoza. The Agency also noted that this medicine is not recommended as the first choice for type-2 diabetes patients (iv). The most recent warning came in March 2013 when the FDA warned that the clinical trials had linked the drug to an “increased risk of pancreatitis, or inflammation of the pancreas, and pre-cancerous cellular changes called pancreatic duct metaplasia.” Read the Drug Safety Communication here.

The Victoza infographic provides important information to type-2 diabetes patients, who are using the drug. Patients who have suffered Victoza side effects like cancer may be able to recover damages for medical bills, lost income, pain and suffering, and other injuries. d’Oliveira & Associates has been investigating these cases and the law firm is ready to answer any questions. They also work with some of the more experienced Victoza lawyers, who are handling these cases, and there are no legal fees unless you receive a settlement or award. Contact the law firm online or call 1-800-992-6878 for a free legal consultation.

(i) Novo Nordisk 2012 Annual Report.
webmedia.novonordisk.com/nncom/images/annual_report/2012/Novo-Nordisk-AR-2012-en.pdf
(ii) Product Website: Understanding Side Effects.
victoza.com/learn/usage-guidelines.aspx
(iii) Endocrine and Metabolic Drug Advisory Committee, April 2009.
fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM148659.pdf%20FDA%20April%202009
(iv) Drug Safety Communication, March 2013.
fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm258826.htm

Read the full story at http://www.prweb.com/releases/2013/9/prweb11070331.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. UCLA Brain Injury Research Center gets NCAA funding for research on sports concussions
2. Why is traumatic brain injury increasing among the elderly?
3. Long-term neuropsychological impairment is common in acute lung injury survivors
4. Experts Offer Advice After Yankee Pitchers Trampoline Injury
5. Spinal cord injury researchers win Apple Award for article on niacin for dyslipidemia
6. Mild traumatic brain injury may contribute to brain network dysfunction
7. Injury-Linked Deaths Vary Widely Among States
8. Most occupational injury and illness costs are paid by the government and private payers
9. Diabetes drug could be a promising therapy for traumatic brain injury
10. Brain-Injury Recovery Varies Widely Among Children
11. Traumatic brain injury the focus of American Headache Society scientific conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/21/2017)... ... , ... Providing broad access to life-saving drugs and rewarding the innovators who ... to address this problem. , That was the message from Dana Goldman, PhD, Leonard ... University of Southern California, who served as the keynote speaker for Western University of ...
(Date:4/21/2017)... ... April 21, 2017 , ... Evoke ... young adults, has kicked off its 4th annual Forum for Innovative Treatment Solutions ... is “Attachment Informed Therapy for Mental Health and Addiction.” , FITS’ 2017 ...
(Date:4/21/2017)... ... April 21, 2017 , ... The adage “Show, don’t ... the next project in the company’s esteemed VISION House demonstration project series. Manifesting the ... the amount of resources they need to live affordably and abundantly without unduly taxing ...
(Date:4/21/2017)... ... April 21, 2017 , ... Crossover Symmetry , ... , an active lifestyle company that provides Human Performance Training and education to ... offers, first responders, military officers and others in service through the development and ...
(Date:4/21/2017)... ... April 21, 2017 , ... Northern California Medical ... Care Spring Symposium on April 1, 2017 in Santa Rosa. This well-attended annual ... healthcare providers an opportunity to learn about cutting edge treatments, to collaborate, share ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... 2017 /PRNewswire/ - CRH Medical Corporation (TSX: CRH) (NYSE MKT: CRHM) (the "Company"), ... Healthcare Investor Conference 2017 at the Sheraton Hotel in ... Executive Officer of the Company is scheduled to present on Tuesday, ... and the Chairman of the Board, Tony Holler ... ...
(Date:4/19/2017)... 2017 Global Surgical Drainage Device Market: Overview ... to remove excess liquid and air. The fluid to ... or lymph. Surgical drains are used in a wide ... surgery, cardiovascular surgery, neurosurgery, plastic surgery etc. Common use ... accumulation of fluid e.g. blood or pus. Surgical drains ...
(Date:4/19/2017)... 19, 2017  Sorrento Therapeutics, Inc. (NASDAQ: ... company developing new treatments for cancer and other ... its previously announced underwritten public offering of 23,625,084 ... offering price of $2.00 per share, before deducting ... payable by Sorrento.  The net proceeds to Sorrento ...
Breaking Medicine Technology: